Brought to you by 
Jazz and Azur combine to form new Irish specialty pharma
04 Oct 2011
Executive Summary
Publicly traded Jazz Pharmaceuticals Inc. (CNS diseases) is merging with fellow drug in-licenser, privately held Azur Pharma Ltd., to form the combined company Jazz Pharmaceuticals PLC, which will be headquartered in Ireland, file with the SEC, and trade on Nasdaq.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Jazz and Azur combine to form new Irish specialty pharma
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice